

Beyond Air announces sale of 85% of NeuroNOS to XTL Biopharmaceuticals, gaining cash, shares, and milestones, as XAIR stock jumps 165% premarket.
You can purchase shares of Beyond Air (NASDAQ:XAIR) through any online brokerage.
Other companies in Beyond Air’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Beyond Air has a consensus price target of $352.50.
The stock price for Beyond Air (NASDAQ: XAIR) is $2.5316 last updated November 11, 2026 at 4:01 PM EST.
There are no upcoming dividends for Beyond Air.
Beyond Air does not have any upcoming earnings scheduled.
There is no upcoming split for Beyond Air.
Beyond Air is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air,...